Caseware UK (AP4) 2025.0.111 2025.0.111 2025-12-312025-12-31true41truetruetrue39false2025-01-01truefalsefalse 01254437 2025-01-01 2025-12-31 01254437 2024-01-01 2024-12-31 01254437 2025-12-31 01254437 2024-12-31 01254437 2024-01-01 01254437 c:Director2 2025-01-01 2025-12-31 01254437 c:Director3 2025-01-01 2025-12-31 01254437 c:Director4 2025-01-01 2025-12-31 01254437 c:Director5 2025-01-01 2025-12-31 01254437 c:RegisteredOffice 2025-01-01 2025-12-31 01254437 d:MotorVehicles 2025-01-01 2025-12-31 01254437 d:MotorVehicles 2025-12-31 01254437 d:MotorVehicles 2024-12-31 01254437 d:MotorVehicles d:OwnedOrFreeholdAssets 2025-01-01 2025-12-31 01254437 d:FurnitureFittings 2025-01-01 2025-12-31 01254437 d:FurnitureFittings 2025-12-31 01254437 d:FurnitureFittings 2024-12-31 01254437 d:FurnitureFittings d:OwnedOrFreeholdAssets 2025-01-01 2025-12-31 01254437 d:OwnedOrFreeholdAssets 2025-01-01 2025-12-31 01254437 d:CurrentFinancialInstruments 2025-12-31 01254437 d:CurrentFinancialInstruments 2024-12-31 01254437 d:CurrentFinancialInstruments d:WithinOneYear 2025-12-31 01254437 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 01254437 e:UnitedKingdom 2025-01-01 2025-12-31 01254437 e:UnitedKingdom 2024-01-01 2024-12-31 01254437 e:RestEuropeOutsideUK 2025-01-01 2025-12-31 01254437 e:RestEuropeOutsideUK 2024-01-01 2024-12-31 01254437 e:RestWorldOutsideUK 2025-01-01 2025-12-31 01254437 e:RestWorldOutsideUK 2024-01-01 2024-12-31 01254437 d:UKTax 2025-01-01 2025-12-31 01254437 d:UKTax 2024-01-01 2024-12-31 01254437 d:ShareCapital 2025-12-31 01254437 d:ShareCapital 2024-12-31 01254437 d:ShareCapital 2024-01-01 01254437 d:RetainedEarningsAccumulatedLosses 2025-01-01 2025-12-31 01254437 d:RetainedEarningsAccumulatedLosses 2025-12-31 01254437 d:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 01254437 d:RetainedEarningsAccumulatedLosses 2024-12-31 01254437 d:RetainedEarningsAccumulatedLosses 2024-01-01 01254437 d:AcceleratedTaxDepreciationDeferredTax 2025-12-31 01254437 d:AcceleratedTaxDepreciationDeferredTax 2024-12-31 01254437 c:OrdinaryShareClass1 2025-01-01 2025-12-31 01254437 c:OrdinaryShareClass1 2025-12-31 01254437 c:OrdinaryShareClass1 2024-12-31 01254437 c:FRS102 2025-01-01 2025-12-31 01254437 c:Audited 2025-01-01 2025-12-31 01254437 c:FullAccounts 2025-01-01 2025-12-31 01254437 c:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 01254437 6 2025-01-01 2025-12-31 01254437 f:PoundSterling 2025-01-01 2025-12-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 01254437










ALFA CHEMICALS LIMITED










ANNUAL REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 
ALFA CHEMICALS LIMITED
 

COMPANY INFORMATION


Directors
S C Bungay 
Dr T W Mathers 
R M Parr 
Dr E K Wale 




Registered number
01254437



Registered office
Arc House
Terrace Road South

Binfield

Bracknell

Berkshire

RG42 4PZ




Independent auditor
James Cowper Kreston Audit
Chartered Accountants and Statutory Auditor

Apex

Forbury Road

Reading

Berkshire

RG1 1AX





 
ALFA CHEMICALS LIMITED
 

CONTENTS



Page
Strategic report
1 - 2
Directors' report
3 - 4
Independent auditor's report
5 - 7
Statement of comprehensive income
8
Balance sheet
9
Statement of changes in equity
10
Notes to the financial statements
11 - 22


 
ALFA CHEMICALS LIMITED
 

STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025

 
Business review and future developments
 
The company operates in highly competitive markets and delivered a 5% increase in turnover, from £18.12m in 2024 to £18.98m in 2025.

Market conditions remained challenging throughout the year. In response, the Company continued to strengthen its resilience by deepening distributor relationships, expanding into new markets with new principals, and implementing targeted sales initiatives to drive organic growth. The manufactured product range launched in 2023 has continued to perform strongly, with an established global distribution network providing a platform for future growth.

Performance across the divisions reflected both opportunities and market developments. The Industrial division benefited from increased sales, driven by higher customer stockholding following the discontinuation of a significant product range early in the year. This was offset by a decline in the Pharmaceutical division, specifically in sales of legacy, custom-manufactured agricultural products supplied to US customers, which have become less viable in the modern commercial environment. Overall, this highlights the importance and strength of the Company’s diversified market exposure.

The Company continues to differentiate itself through a focus on service quality and reliability, which contributed to an increase in gross profit margins from 25% in 2024 to 26% in 2025.

Profit for 2025 decreased marginally by 1% to £0.6m, compared to £0.7m in 2024. The improvement in gross margin enabled the Company to broadly maintain profitability whilst absorbing higher operating costs. These cost increases reflect ongoing investment in people, systems and customer engagement, as well as the impact of inflationary pressures.

The company remains profitable, well-positioned within its markets and focused on strengthening relationships with key customer and supplier to support sustainable long-term growth and continued market resilience.

Principal risks and uncertainties
 
The company seeks to manage the risk of losing Principals by the provision of added value services that they would be unable to provide. In addition the company focuses on retaining and increasing its customer base by improving the service to customers by reducing response times in the supply of products and also in the handling of customer queries, while maintaining strong relationships and local representation with key customers.

The main financial risks arising from the company's activities are credit risk, exchange rate and liquidity risk. These are monitored by the board of directors and were not considered to be significant at the balance sheet date.

The company's policy in respect of credit risk is to require appropriate credit checks on potential customers before sales are made and to monitor payments against contractual agreements for existing customers.

The company's policy in respect of exchange rate risk is to maintain bank accounts denominated in Euros and US Dollars to facilitate day to day trading transactions; exposure to movements in exchange rates is mitigated by transferring funds into sterling accounts on a timely basis.

The company's policy in respect of liquidity risk is to maintain readily accessible bank deposit accounts to ensure the company has sufficient funds for operation.

Financial key performance indicators
 
Turnover, margin and net profit are the main measures used to monitor the performance of the company. Each of these measures is discussed in the business review.

 
Page 1

 
ALFA CHEMICALS LIMITED
 

STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025


This report was approved by the board and signed on its behalf.



S C Bungay
Director

Date: 8 June 2026

Page 2

 
ALFA CHEMICALS LIMITED
 

 
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025

The directors present their report and the financial statements for the year ended 31 December 2025.

Principal activity

The company's principal activity is the distribution of specialty raw materials from, primarily, overseas principals to the Pharmaceutical, Personal Care and Industrial markets in the UK and Ireland.

Results and dividends

The profit for the year, after taxation, amounted to £401,651 (2024 - £500,151).

Interim dividends of £305,629 (2024: £1,098,863) were paid to ordinary shareholders during the year. The directors do not recommend the payment of a final dividend.

Directors

The directors who served during the year were:

S C Bungay 
Dr T W Mathers 
R M Parr 
Dr E K Wale 

Directors' responsibilities statement

The directors are responsible for preparing the Strategic report, the Directors' report and the financial statements in accordance with applicable law and regulations.
 
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

 In preparing these financial statements, the directors are required to:


select suitable accounting policies for the company's financial statements and then apply them consistently;

make judgments and accounting estimates that are reasonable and prudent;

state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and to enable them to ensure that the financial statements comply with the Companies Act 2006They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Political and charitable contributions

During the year the company made charitable contributions of £33,183 (2024: £27,463). There were no political contributions.

Page 3

 
ALFA CHEMICALS LIMITED
 

 
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025

Qualifying third-party indemnity provisions

The company has maintained directors' liability insurance in respect of its directors.

Post balance sheet events

There were no post year end balance sheet events.

Disclosure of information to auditor

Each of the persons who are directors at the time when this Directors' report is approved has confirmed that:
 
so far as the director is aware, there is no relevant audit information of which the company's auditor is unaware, and

the director has taken all the steps that ought to have been taken as a director in order to be aware of any relevant audit information and to establish that the company's auditor is aware of that information.

Auditor

The auditor, James Cowper Kreston Auditwill be proposed for reappointment in accordance with section 485 of the Companies Act 2006.

This report was approved by the board and signed on its behalf.
 





S C Bungay
Director
Date: 8 June 2026

Page 4

 
ALFA CHEMICALS LIMITED
 

 
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF ALFA CHEMICALS LIMITED
 

Opinion


We have audited the financial statements of Alfa Chemicals Limited (the 'company') for the year ended 31 December 2025, which comprise the Statement of comprehensive income, the Balance sheet, the Statement of changes in equity and the related notes, including a summary of significant accounting policiesThe financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).


In our opinion the financial statements:


give a true and fair view of the state of the company's affairs as at 31 December 2025 and of its profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.


Basis for opinion


We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.


Conclusions relating to going concern


In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.


Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.


Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.


Other information


The other information comprises the information included in the Annual Report other than the financial statements and our Auditor's report thereon. The directors are responsible for the other information contained within the Annual ReportOur opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.


We have nothing to report in this regard.


Page 5

 
ALFA CHEMICALS LIMITED
 

 
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF ALFA CHEMICALS LIMITED (CONTINUED)


Opinion on other matters prescribed by the Companies Act 2006
 

In our opinion, based on the work undertaken in the course of the audit:


the information given in the Strategic report and the Directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the Strategic report and the Directors' report have been prepared in accordance with applicable legal requirements.


Matters on which we are required to report by exception
 

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic report or the Directors' report.


We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:


adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.


Responsibilities of directors
 

As explained more fully in the Directors' responsibilities statement set out on page 3, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.


In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.


Page 6

 
ALFA CHEMICALS LIMITED
 

 
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF ALFA CHEMICALS LIMITED (CONTINUED)


Auditor's responsibilities for the audit of the financial statements
 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.


Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance.

The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

The specific procedures for this engagement that we designed and performed to detect material misstatements in respect of irregularities, including fraud, were as follows:
 
Enquiry of management and those charged with governance around actual and potential litigation and claims;
Enquiry of management and those charged with governance to identify any material instances of non compliance with laws and regulations
Reviewing financial statement disclosures and testing to supporting documentation to assess compliance with applicable laws and regulations;
Performing audit work to address the risk of irregularities due to management override of controls, including testing of journal entries and other adjustments for appropriateness, evaluating the business rationale of significant transactions.



A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditor's report.


Use of our report
 

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an Auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members, as a body, for our audit work, for this report, or for the opinions we have formed.




Alexander Peal BSc (Hons) FCA DChA (Senior Statutory Auditor)
for and on behalf of
James Cowper Kreston Audit
Chartered Accountants and Statutory Auditor
Apex
Forbury Road
Reading
Berkshire
RG1 1AX

8 June 2026
Page 7

 
ALFA CHEMICALS LIMITED
 

STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2025

2025
2024
Note
 £
£

  

Turnover
 4 
18,977,372
18,124,907

Cost of sales
  
(14,071,509)
(13,540,600)

Gross profit
  
4,905,863
4,584,307

Administrative expenses
  
(4,509,712)
(4,061,204)

Other operating income
 5 
138,670
130,923

Operating profit
 6 
534,821
654,026

Interest receivable and similar income
  
23,660
21,012

Interest payable and similar expenses
  
(1,299)
-

Profit before tax
  
557,182
675,038

Tax on profit
 10 
(155,531)
(174,887)

Profit for the financial year
  
401,651
500,151

There was no other comprehensive income for 2025 (2024: £NIL).

The notes on pages 11 to 22 form part of these financial statements.

Page 8

 
ALFA CHEMICALS LIMITED
REGISTERED NUMBER: 01254437

BALANCE SHEET
AS AT 31 DECEMBER 2025

2025
2024
Note
£
£

Fixed assets
  

Tangible assets
 12 
114,435
93,202

Investments
 13 
6,306
6,306

  
120,741
99,508

Current assets
  

Stocks
 14 
2,112,849
2,359,306

Debtors: amounts falling due within one year
 15 
2,590,124
2,051,600

Cash at bank and in hand
 16 
1,629,057
1,948,081

  
6,332,030
6,358,987

Creditors: amounts falling due within one year
 17 
(1,850,333)
(1,957,525)

Net current assets
  
 
 
4,481,697
 
 
4,401,462

Total assets less current liabilities
  
4,602,438
4,500,970

Provisions for liabilities
  

Deferred tax
 18 
(26,234)
(20,788)

  
 
 
(26,234)
 
 
(20,788)

Net assets
  
4,576,204
4,480,182


Capital and reserves
  

Called up share capital 
 19 
100,000
100,000

Profit and loss account
 20 
4,476,204
4,380,182

  
4,576,204
4,480,182


The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




S C Bungay
Director
Date: 8 June 2026

The notes on pages 11 to 22 form part of these financial statements.

Page 9

 
ALFA CHEMICALS LIMITED
 

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2025


Called up share capital
Profit and loss account
Total equity

£
£
£


At 1 January 2024
100,000
4,978,894
5,078,894



Profit for the year
-
500,151
500,151

Dividends: Equity capital
-
(1,098,863)
(1,098,863)



At 1 January 2025
100,000
4,380,182
4,480,182



Profit for the year
-
401,651
401,651

Dividends: Equity capital
-
(305,629)
(305,629)


At 31 December 2025
100,000
4,476,204
4,576,204


The notes on pages 11 to 22 form part of these financial statements.

Page 10

 
ALFA CHEMICALS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

1.


General information

Alfa Chemicals Limited is a private company limited by shares and incorporated in England and Wales. Its registered head office is Arc House, Terrace Road South, Binfield, Bracknell, Berkshire, RG42 4PZ.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the company's accounting policies (see note 3).

The following principal accounting policies have been applied:

 
2.2

Financial Reporting Standard 102 - reduced disclosure exemptions

The company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by the FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":
the requirements of Section 7 Statement of Cash Flows;
the requirements of Section 3 Financial Statement Presentation paragraph 3.17(d);
the requirements of Section 11 Financial Instruments paragraphs 11.42, 11.44 to 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b) and 11.48(c);
the requirements of Section 12 Other Financial Instruments paragraphs 12.26 to 12.27, 12.29(a), 12.29(b) and 12.29A.

This information is included in the consolidated financial statements of Alfa Chemicals Group Limited as at 31 December 2025 and these financial statements may be obtained from Companies House.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the company has transferred the significant risks and rewards of ownership to the buyer;
the company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Page 11

 
ALFA CHEMICALS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

 
2.4

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Motor vehicles
-
3%
straight line per month
Fixtures and fittings
-
2%
straight line per month

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.5

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.6

Stocks

Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost is based on the cost of purchase on a first in, first out basis. Net realisable value is based on estimated selling price less additional costs to completion and disposal.

 
2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Page 12

 
ALFA CHEMICALS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

 
2.9

Financial instruments

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Basic financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

 
2.10

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 13

 
ALFA CHEMICALS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

 
2.11

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


 
2.12

Foreign currency translation

Functional and presentation currency

The company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

 
2.13

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Page 14

 
ALFA CHEMICALS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

 
2.14

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.15

Pensions

Defined contribution pension plan

The company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the company in independently administered funds.


3.


Judgements in applying accounting policies and key sources of estimation uncertainty

The preparation of the financial statements require management to make judgements, estimates and assumptions that affect the amounts reported for assets and liabilities as at the balance sheet date and the amounts reported for revenues and expenses during the year. However, the nature of estimation means that actual outcomes could differ from those estimates. The following judgements and estimates have had the most significant effect on amounts recognised in the financial statements.

Stock provisions

Provisions are estimated by the company in respect of specific stocks based upon the age of the stock and knowledge of known issues.


4.


Turnover

Analysis of turnover by country of destination:

2025
2024
£
£

United Kingdom
16,450,965
13,694,510

Rest of Europe
1,987,797
2,059,057

Rest of the World
538,610
2,371,340

18,977,372
18,124,907



5.


Other operating income

2025
2024
£
£

Management charges
138,670
130,923


Page 15

 
ALFA CHEMICALS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

6.


Operating profit

The operating profit is stated after charging:

2025
2024
£
£

Depreciation
46,853
42,707

Exchange differences
68,816
8,660

Other operating lease rentals
82,123
84,392


7.


Auditor's remuneration

2025
2024
£
£

Fees payable to the company's auditor for the audit of the company's financial statements
18,850
17,835


8.


Employees

Staff costs, including directors' remuneration, were as follows:


2025
2024
£
£

Wages and salaries
2,740,587
2,554,715

Social security costs
358,242
294,789

Cost of defined contribution scheme
138,628
124,178

3,237,457
2,973,682


The average monthly number of employees, including the directors, during the year was as follows:


        2025
        2024
            No.
            No.







Trading
24
23



Administration
17
16

41
39

Page 16

 
ALFA CHEMICALS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

9.


Directors' remuneration

2025
2024
£
£

Directors' emoluments
814,169
        754,592

During the year retirement benefits were accruing to 4 directors (2024 - 4) in respect of defined contibution pension schemes.

The highest paid director received remuneration of £188,878 (2024 - £182,975).

The value of the company's contributions paid to a defined contribution pension scheme in respect of the highest paid director amounted to £9,932 (2024 - £9,106).

The directors are considered to be the key management personnel of the company.


10.


Taxation


2025
2024
£
£

Corporation tax


Current tax on profits for the year
150,085
180,355


150,085
180,355


Total current tax
150,085
180,355

Deferred tax


Origination and reversal of timing differences
5,446
(5,472)

Adjustments in respect of prior periods
-
4

Total deferred tax
5,446
(5,468)


Tax on profit
155,531
174,887
Page 17

 
ALFA CHEMICALS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
 
10.Taxation (continued)


Factors affecting tax charge for the year

The tax assessed for the year is higher than (2024 - higher than) the standard rate of corporation tax in the UK of 25% (2024 - 25%). The differences are explained below:

2025
2024
£
£


Profit on ordinary activities before tax
557,182
675,038


Profit on ordinary activities multiplied by standard rate of corporation tax in the UK of 25% (2024 - 25%)
139,296
168,760

Effects of:


Expenses not deductible for tax purposes
17,643
18,339

Adjustments to tax charge in respect of previous periods - deferred tax
-
4

Group relief
(1,408)
(12,216)

Total tax charge for the year
155,531
174,887


11.


Dividends

2025
2024
£
£


Dividends paid on equity capital
305,629
1,098,863

Page 18

 
ALFA CHEMICALS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

12.


Tangible fixed assets


Motor vehicles
Fixtures and fittings
Total

£
£
£



Cost 


At 1 January 2025
38,500
467,167
505,667


Additions
-
74,131
74,131


Disposals
(38,500)
(70,224)
(108,724)



At 31 December 2025

-
471,074
471,074



Depreciation


At 1 January 2025
38,500
373,965
412,465


Charge for the year
-
46,853
46,853


Disposals
(38,500)
(64,179)
(102,679)



At 31 December 2025

-
356,639
356,639



Net book value



At 31 December 2025
-
114,435
114,435



At 31 December 2024
-
93,202
93,202


13.


Fixed asset investments





Investments in subsidiary companies

£



Cost 


At 1 January 2025
6,306



At 31 December 2025
6,306




The investment represents 100% of the issued share capital (€7,000, translated at the investment date of 1 January 2019) of Alfa Chemicals Nordic ApS, a company incorporated in Denmark. The company’s principal activity is the sale of raw materials for the chemical industry and its registered address was Bredgade 20A, 2nd Floor, DK-1260, Copenhagen, Denmark.


Page 19

 
ALFA CHEMICALS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

14.


Stocks

2025
2024
£
£

Finished goods and goods for resale
2,112,849
2,359,306



15.


Debtors

2025
2024
£
£


Trade debtors
2,434,481
1,734,847

Amounts owed by group undertakings
-
224,156

Other debtors
155,643
92,597

2,590,124
2,051,600



16.


Cash and cash equivalents

2025
2024
£
£

Cash at bank and in hand
1,629,057
1,948,081



17.


Creditors: Amounts falling due within one year

2025
2024
£
£

Trade creditors
963,172
1,065,255

Corporation tax
40,402
69,628

Other taxation and social security
455,447
397,311

Other creditors
78,954
172,431

Accruals and deferred income
312,358
252,900

1,850,333
1,957,525


Page 20

 
ALFA CHEMICALS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

18.


Deferred taxation




2025


£






At beginning of year
(20,788)


Credited to profit or loss
(5,446)



At end of year
(26,234)

The provision for deferred taxation is made up as follows:

2025
2024
£
£


Fixed asset timing differences
(26,234)
(20,788)

(26,234)
(20,788)


19.


Share capital

2025
2024
£
£
Allotted, called up and fully paid



100,000 (2024 - 100,000) Ordinary shares of £1.00 each
100,000
100,000



20.


Reserves

Profit and loss account

Includes all current and prior periods retained profits and losses.


21.


Pension commitments

The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The pension cost charge represents contributions payable by the company to the fund and amounted to £138,628 (2024: £124,178).


22.


Related party transactions

The company has taken advantage of the exemption under FRS 102 not to disclose related party transactions with wholly owned group companies.

During the year the company paid dividends of £305,629 (2024: £1,098,863) to the shareholders.

Page 21

 
ALFA CHEMICALS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

23.


Controlling party

The ultimate parent company is Alfa Chemicals Group Limited, a company incorporated in England.

The largest and smallest group in which the results of the company are consolidated is that headed by Alfa Chemicals Group Limited. The consolidated financial statements of this company are available to the public from:

The Registrar of Companies
Companies House
2 Crown Way
Cardiff
CF4 3UZ

No other group financial statements include the results of the company.


Page 22